Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...

Using a newly developed mouse model, researchers found that exposure to the SARS-CoV-2 spike protein alone was enough to induce COVID-19-like symptoms including severe inflammation in the lungs.

Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human lung cells through optimized interaction with heparan sulfate, a sugar ...

A healthy person will show no signs of lung inflammation, therefore no yellow areas. That’s where the body is trying to block the infection. As the video shows, the SARS-CoV-2 virus goes ...

WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current antivirals like Paxlovid. WEHI researchers have developed a drug compound that ...

the characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells in the lungs remain elusive. Here we conducted integrated single-cell profiling of SARS-CoV-2 ...

A SARS-CoV-2 particle enters a person's nose or mouth and floats in the airway until it brushes against a lung cell that has an ACE2 receptor on the surface. The virus binds to that cell ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

Learn about our Editorial Policies. At the height of the SARS-CoV-2 pandemic, researchers in Thomas Marichal’s immunophysiology laboratory at the University of Liège were studying samples collected ...

Tucked away on Mount Desert Island off the coast of Maine, the Jackson Laboratory (JAX) may seem removed from the pandemic ...